NuuVim Review

What NuuVim charges

• Semaglutide: $79 — presented as $79 a month but billed $237 once for the first three months
• Semaglutide: $133 — presented as $133 a month but billed $399 once for three months
• Semaglutide: $79 — presented as $79 a month but billed $237 once for the first three months; priced identically to the injection
• Tirzepatide: $133 — presented as $133 a month but billed $399 once for the first three months
• Tirzepatide: $199.67 — presented as $199.67 a month but billed $599 once for three months
• Tirzepatide: $133 — presented as $133 a month but billed $399 once for the first three months; priced identically to the injection

Every figure is one three-month payment

Each pricing card carries a per-month rate, the total actually charged, the words first three months and the phrase three-month billing plan.

So none of these is a monthly charge, and each row is recorded as not monthly with the total kept beside the rate.

New patients and current users get separate cards, and the introductory rate is scoped to the first three months rather than to the whole plan.

Two pharmacies, named with addresses

It names Hallandale Pharmacy at a street address in Fort Lauderdale, Florida, and VialsRX at a street address in Houston, Texas, each with its own website.

Both were screened against the federal warning-letter table separately from the seller, and neither carries one.

Its own words on the category are unambiguous: "*Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality."

The oral form and the injection cost the same

For each molecule, the daily sublingual liposomal liquid is priced identically to the weekly injection.

That is unusual, and it is stated on the same pricing page rather than hidden in a comparison.

Nothing about the route changes the figure, so a reader choosing between them is choosing on how they want to take it rather than on cost.

Its comparison table and its coverage line both need reading twice

The table is headed "How NuuVim Stacks Up — Lower prices, zero hidden fees" and carries a "Lowest Price!" badge on its own row. Those are its words, quoted rather than endorsed.

It does label the other columns honestly — "competitor information … based on publicly available pricing as of March 2026" — and nothing from those rows is recorded here; its own row was checked against its product cards in both directions and matches.

Its coverage line qualifies itself in the very next sentence: "Currently offering Services in all 50 states plus Washington D.C. Some Services may not be available in all 50 states or Washington D.C."

How we verified this

• Read each pricing card and recorded the three-month total the seller prints beside every per-month figure, filing each row as not monthly.
• Checked its own row of its comparison table against its product cards in both directions, and filed nothing from the columns it labels as competitor pricing.
• Read its fifty-state line together with the sentence that immediately qualifies it, and credited no coverage claim from either.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand and both named pharmacies against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, through a matcher that normalises both the query and the filed company name before comparing, with a positive and a nonsense control in the same run.